Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancerHideho Endo(Tokyo Medical and Dental University), Ken‐ichi Kozaki(Okayama University)CarcinogenesisDecember 10, 201210.1093/carcin/bgs376Cited by 67SaveCiteExport RISWatch citationsRelated PapersAntiparkinson Drug Benztropine Suppresses Tumor Growth, Circulating Tumor Cells, and Metastasis by Acting on SLC6A3/DAT and Reducing STAT3|Cancers|2020|49Changes in Metallothionein Isoform Expression in the Bones of Ovariectomized Rats|Journal of Hard Tissue Biology|2016|0